Article
Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan.
Environmental health and preventive medicine - 24 Oct 2017
Koda Masahide, Iwasaki Motoki, Yamano Yuko, Lu Xi, Katoh Takahiko
Abstract excerpt
BACKGROUND: Heterocyclic aromatic amines (HAAs) may confer prostate cancer risk; however, the evidence is inconclusive and the activity of HAA-metabolizing enzymes is modulated by gene variants. The purpose of our study was to determine whether there was evidence of an association between HAA intake, polymorphisms in NAT2, CYP1A1, and CYP1A2 and prostate cancer risk in Japanese men. METHODS: Secondary data...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
